Answer
During Zypadhera treatment, fluvoxamine significantly inhibits olanzapine metabolism through CYP1A2 inhibition, increasing olanzapine exposure; a lower starting olanzapine dose should be considered with existing fluvoxamine use, or a dose decrease if fluvoxamine is initiated.
Sources for this answer
- ZYPADHERA 210 mg, 300 mg and 405 mg powder and solvent for prolonged release suspension for injectionNeon Healthcare Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 2Document updated
Sources checked